ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael P. Macris
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macris, M. P.
Right arrow Articles by Jarvik, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macris, M. P.
Right arrow Articles by Jarvik, R. K.

Ann Thorac Surg 1997;63:367-370
© 1997 The Society of Thoracic Surgeons


Original Article: Cardiovascular

Development of an Implantable Ventricular Assist System

Michael P. Macris, MD, Steven M. Parnis, O. H. Frazier, MD, John M. Fuqua, Jr, Robert K. Jarvik, MD

Cullen Cardiovascular Research Laboratories, Department of Cardiovascular Surgical Research, Texas Heart Institute, Houston, Texas, and Transicoil Inc, Valley Forge, Pennsylvania

Background. This study describes the present state of progress in the development of the Jarvik 2000 ventricular assist system.

Methods. Designed for implantation in the human thorax, the system consists of a small (25 cm3, 90 g) intraventricular axial-flow blood pump that transmits power and data via internal electronics and a transcutaneous energy transfer system. The pump is powered by portable internal and external polymer lithium ion batteries. The only moving part, the pump rotor, contains a permanent magnet of a brushless direct-current motor that mounts an axial-flow impeller and partial magnetic thrust support, with blood-immersed radial and thrust bearings. The motor uses a redundant coil and electric lead design, which permits continued operation in case of wire breakage.

Results. Seven calves have been supported for an average of 107 days (range, 40 to 162 days) with prototypes of the Jarvik 2000 ventricular assist system. No physiologic complications have occurred. When its user is at rest, the pump produces flows of 5 to 6 L/min with a decreased arterial pulse contour. Renal and hepatic functions have remained normal throughout the duration of all studies. Mean plasma free hemoglobin levels ranged from 4.3 to 11.4 mg/dL (mean, 6.3 mg/dL) for each study. Pathologic analyses of the heart and kidneys revealed no damage related to the device.

Conclusions. These studies indicate that the Jarvik 2000 ventricular assist system is feasible in animals and holds promise for long-term support of patients.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
O. H. Frazier, T. J. Myers, S. Westaby, and I. D. Gregoric
Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection
Ann. Thorac. Surg., January 1, 2004; 77(1): 133 - 142.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. J. Ankersmit, G. Wieselthaler, B. Moser, S. Gerlitz, G. Roth, G. Boltz-Nitulescu, and E. Wolner
Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump
J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 557 - 561.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Ochiai, L. A.R. Golding, A. L. Massiello, A. L. Medvedev, R. L. Gerhart, J.-F. Chen, M. Takagaki, and K. Fukamachi
In vivo hemodynamic performance of the Cleveland Clinic CorAide blood pump in calves
Ann. Thorac. Surg., September 1, 2001; 72(3): 747 - 752.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
H. M Reul and M. Akdis
Blood pumps for circulatory support
Perfusion, July 1, 2000; 15(4): 295 - 311.
[PDF]


Home page
CirculationHome page
G. M. Wieselthaler, H. Schima, M. Hiesmayr, R. Pacher, G. Laufer, G. P. Noon, M. DeBakey, and E. Wolner
First Clinical Experience With the DeBakey VAD Continuous-Axial-Flow Pump for Bridge to Transplantation
Circulation, February 1, 2000; 101(4): 356 - 359.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Westaby, T. Katsumata, R. Houel, R. Evans, D. Pigott, O. H. Frazier, and R. Jarvik
Jarvik 2000 Heart : Potential for Bridge to Myocyte Recovery
Circulation, October 13, 1998; 98(15): 1568 - 1574.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Jarvik, S. Westaby, T. Katsumata, D. Pigott, and R. D. Evans
LVAD Power Delivery: A Percutaneous Approach to Avoid Infection
Ann. Thorac. Surg., February 1, 1998; 65(2): 470 - 473.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. A. Cooley
Early Development of Congenital Heart Surgery: Open Heart Procedures
Ann. Thorac. Surg., November 1, 1997; 64(5): 1544 - 1548.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Westaby, T. Katsumata, R. Evans, D. Pigott, D. P. Taggart, and R. K. Jarvik
THE JARVIK 2000 OXFORD SYSTEM: INCREASING THE SCOPE OF MECHANICAL CIRCULATORY SUPPORT
J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 467 - 474.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The Society of Thoracic Surgeons.